Literature DB >> 32449915

Community antibiotic prescribing for children in France from 2015 to 2017: a cross-sectional national study.

Nhung T H Trinh1,2, Robert Cohen3,4, Magali Lemaitre2, Pierre Chahwakilian5, Gregory Coulthard2, Tim A Bruckner6, Dejan Milic2, Corinne Levy3,7, Martin Chalumeau1,8, Jérémie F Cohen1,8.   

Abstract

OBJECTIVES: To assess recent community antibiotic prescribing for French children and identify areas of potential improvement.
METHODS: We analysed 221 768 paediatric (<15 years) visits in a national sample of 680 French GPs and 70 community paediatricians (IQVIA's EPPM database), from March 2015 to February 2017, excluding well-child visits. We calculated antibiotic prescription rates per 100 visits, separately for GPs and paediatricians. For respiratory tract infections (RTIs), we described broad-spectrum antibiotic use and duration of treatment. We used Poisson regression to identify factors associated with antibiotic prescribing.
RESULTS: GPs prescribed more antibiotics than paediatricians [prescription rate 26.1 (95% CI 25.9-26.3) versus 21.6 (95% CI 21.0-22.2) per 100 visits, respectively; P < 0.0001]. RTIs accounted for more than 80% of antibiotic prescriptions, with presumed viral RTIs being responsible for 40.8% and 23.6% of all antibiotic prescriptions by GPs and paediatricians, respectively. For RTIs, antibiotic prescription rates per 100 visits were: otitis, 68.1 and 79.8; pharyngitis, 67.3 and 53.3; sinusitis, 67.9 and 77.3; pneumonia, 80.0 and 99.2; bronchitis, 65.2 and 47.3; common cold, 21.7 and 11.6; bronchiolitis 31.6 and 20.1; and other presumed viral RTIs, 24.1 and 11.0, for GPs and paediatricians, respectively. For RTIs, GPs prescribed more broad-spectrum antibiotics [49.8% (95% CI 49.3-50.3) versus 35.6% (95% CI 34.1-37.1), P < 0.0001] and antibiotic courses of similar duration (P = 0.21). After adjustment for diagnosis, antibiotic prescription rates were not associated with season and patient age, but were significantly higher among GPs aged ≥50 years.
CONCLUSIONS: Future antibiotic stewardship campaigns should target presumed viral RTIs, broad-spectrum antibiotic use and GPs aged ≥50 years.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32449915     DOI: 10.1093/jac/dkaa162

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  Antibiotic prescribing for children with upper respiratory tract infection: a Finnish nationwide 7-year observational study.

Authors:  Matti Korppi; Paula Heikkilä; Sauli Palmu; Heini Huhtala; Péter Csonka
Journal:  Eur J Pediatr       Date:  2022-05-23       Impact factor: 3.860

2.  Impact of Coronavirus Disease 2019 (COVID-19) Pandemic on Pediatric Infectious Disease Research.

Authors:  Eden Bensoussan; Naim Ouldali; Shai Ashkenazi; François Angoulvant; Robert Cohen; Corinne Levy
Journal:  J Pediatr       Date:  2020-11-30       Impact factor: 4.406

3.  Paediatric outpatient prescriptions in France between 2010 and 2019: A nationwide population-based study: Paediatric outpatient prescriptions in France, 2010 to 2019.

Authors:  Marion Taine; Lucile Offredo; Rosemary Dray-Spira; Alain Weill; Martin Chalumeau; Mahmoud Zureik
Journal:  Lancet Reg Health Eur       Date:  2021-06-07

4.  Outpatient Antibiotic Prescribing Patterns and Appropriateness for Children in Primary Healthcare Settings in Beijing City, China, 2017-2019.

Authors:  Haishaerjiang Wushouer; Kexin Du; Shicai Chen; Yue Zhou; Bo Zheng; Xiaodong Guan; Luwen Shi
Journal:  Antibiotics (Basel)       Date:  2021-10-14

5.  Pediatric Outpatient Prescriptions in Countries With Advanced Economies in the 21st Century: A Systematic Review.

Authors:  Marion Taine; Lucile Offredo; Alain Weill; Rosemary Dray-Spira; Mahmoud Zureik; Martin Chalumeau
Journal:  JAMA Netw Open       Date:  2022-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.